Resgen Limited sets November 14 meeting for September results

Resgen Limited has scheduled a board meeting on November 14, 2026, to consider unaudited financial results for the half-year ended September 30, 2026, after FY26 revenue from operations rose 9.1% to ₹71.08 crore. The disclosure sets the next formal financial reporting milestone for shareholders following the company’s audited FY26 results.

Why is Resgen holding a board meeting on November 14?

Resgen will meet its board of directors on November 14, 2026, to consider and approve unaudited financial results for the half-year ended September 30, 2026, along with other matters. The intimation was issued to BSE on November 10 and identifies the financial-results agenda without providing the underlying September-period numbers.

The meeting is part of the company’s regular results-reporting cycle. In the previous year, Resgen held a board meeting on November 14, 2025, to consider unaudited results for the half-year ended September 30, 2025. Its board also met on May 28, 2026, to approve audited standalone and consolidated financial results for the half-year and year ended March 31, 2026.

The November meeting is important because it will provide the first reported financial update after the FY26 audited results. Until the board considers and releases the unaudited results, the disclosure does not establish whether revenue, margins or profit changed during the six months ended September 2026.

At its eighth annual general meeting on September 30, 2026, shareholders adopted the audited FY26 financial statements and approved the reappointment of Director Abhijeet Oza. The company had earlier shifted its registered office to Maker Chambers V, Nariman Point, Mumbai, effective January 17, 2025.

What did Resgen report in its FY26 audited results?

Resgen reported FY26 revenue from operations of ₹71.08 crore, up 9.1% from ₹65.16 crore in the previous year. Total income from operations was ₹72.72 crore, while profit before tax increased to ₹12.16 crore from ₹11.14 crore.

Profit after tax for FY26 rose 10% to ₹8.77 crore, according to the company’s reported figures. For the half-year ended March 31, 2026, net profit was ₹4.74 crore. These audited results were approved by the board on May 28, 2026.

The company’s audited FY25 results had been approved on May 29, 2025. The statutory auditor’s report for that period carried an unmodified opinion, according to the disclosed board-meeting outcome. The supplied information does not state the audit opinion for FY26.

How do Resgen’s latest half-yearly consolidated figures compare?

Resgen’s consolidated sales for the half-year ended March 2026 were ₹33 crore, compared with ₹38 crore in September 2025 and ₹39 crore in March 2025. The detailed March 2026 snapshot puts net sales at ₹33.20 crore, down 12.33% from ₹37.87 crore in September 2025.

Operating profit excluding other income was ₹6.74 crore for the March 2026 half-year, compared with ₹6.78 crore in September 2025, a decline of 0.59%. Despite lower sales, the operating profit margin was 20%, compared with 18% in September 2025 and equal to the 20% reported for March 2025.

Other income for the March 2026 half-year was ₹2 crore, against nil in the preceding two reported half-years. Depreciation was ₹1 crore, while interest was reported at nil. The reported March 2026 net profit was ₹6 crore on a rounded consolidated basis, and earnings per share were ₹2.94.

What does the upcoming disclosure mean for investors and the pyrolysis oil sector?

The November 14 results will allow investors to assess whether the FY26 revenue and profit growth continued into the September 2026 half-year. The reported FY26 growth came alongside a decline in consolidated sales between September 2025 and March 2026, making the forthcoming revenue, operating-profit and margin figures relevant for evaluating the recent operating trend.

The Managing Director has said that the pyrolysis oil industry continues to attract global interest, supported by tighter plastic-waste regulations and India’s diesel co-processing guidelines. This provides sector context for Resgen’s operations, but the supplied disclosures do not quantify the impact of these factors on the company’s sales, capacity or profitability.

The supplied market comparison places Resgen’s management risk in the average category, while DHP India and certain other peers were described as having excellent management. Resgen was identified as having excellent growth in that comparison, but its one-year return was reported at negative 45.64%, versus positive 67.44% for GP Petroleums and negative 68.64% for Aban Offshore.

These return figures show differing market performance among the named companies, rather than a direct financial comparison of their operations. Investors will need to separate the forthcoming reported financial data from share-price performance and from broad sector commentary, particularly because no September 2026 financial numbers have yet been disclosed.

Conclusion

Resgen’s November 14 board meeting is the next confirmed event for investors after a FY26 in which revenue from operations increased 9.1% to ₹71.08 crore and profit after tax rose 10% to ₹8.77 crore. The available consolidated half-year data also shows lower March 2026 sales than September 2025, while operating margin improved to 20%.

The key item to watch is the company’s unaudited financial results for the half-year ended September 30, 2026, once considered by the board on November 14. Investors can then compare the disclosed sales, operating profit, other income and net profit with the FY26 audited figures and earlier half-year results.